Detalhe da pesquisa
1.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Cell
; 165(1): 35-44, 2016 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26997480
2.
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Cell
; 168(3): 542, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129544
3.
Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 Development.
Immunity
; 45(3): 527-539, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566938
4.
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
N Engl J Med
; 375(9): 819-29, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27433843
5.
Genetic regulation of thymocyte progenitor aging.
Semin Immunol
; 24(5): 303-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559986
6.
Proteolytic histone modification by mast cell tryptase, a serglycin proteoglycan-dependent secretory granule protease.
J Biol Chem
; 289(11): 7682-90, 2014 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24478313
7.
Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a.
Blood
; 119(24): 5715-21, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22555975
8.
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156551
9.
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.
Cancer Immunol Res
; 11(12): 1589-1597, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871333
10.
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Cancer Discov
; 13(3): 580-597, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416874
11.
Influence of FAS on murine mast cell maturation.
Ann Allergy Asthma Immunol
; 106(3): 239-44, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354026
12.
Human mast cells express intracellular TRAIL.
Cell Immunol
; 262(2): 80-3, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20189551
13.
Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy.
Cancer Discov
; 10(11): 1645-1653, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699033
14.
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
J Immunother
; 43(9): 273-282, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925563
15.
PAK4 inhibition improves PD-1 blockade immunotherapy.
Nat Cancer
; 1(1): 46-58, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368780
16.
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov
; 10(8): 1140-1157, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467343
17.
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.
Clin Cancer Res
; 25(7): 2096-2108, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573690
18.
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.
Cell Stem Cell
; 25(4): 542-557.e9, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495780
19.
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
Clin Cancer Res
; 25(3): 1000-1011, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409823
20.
Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules.
Infect Immun
; 76(10): 4489-97, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18644875